{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:30:24Z","timestamp":1794328224901,"version":"4.9.0"},"reference-count":220,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","award":["3081"],"award-info":[{"award-number":["3081"]}],"id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004358","name":"Samsung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004358","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.trsl.2019.03.005","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:09:11Z","timestamp":1553612951000},"page":"39-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":99,"special_numbering":"C","title":["Pathogenesis of fibrostenosing Crohn's disease"],"prefix":"10.1016","volume":"209","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4023-690X","authenticated-orcid":false,"given":"Jiannan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satya","family":"Kurada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotsna","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Rieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2019.03.005_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-7113-8_1","article-title":"Human fibrotic diseases: current challenges in fibrosis research","volume":"1627","author":"Rosenbloom","year":"2017","journal-title":"Methods Mol Biol."},{"key":"10.1016\/j.trsl.2019.03.005_bib0002","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.trsl.2019.03.005_bib0003","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/S0140-6736(17)30866-8","article-title":"Idiopathic pulmonary fibrosis","volume":"389","author":"Richeldi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2019.03.005_bib0004","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1007\/s10620-016-4254-7","article-title":"Targeting hepatic fibrosis in autoimmune hepatitis","volume":"61","author":"Montano-Loza","year":"2016","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.trsl.2019.03.005_bib0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.mayocp.2017.04.010","article-title":"Crohn disease: epidemiology, diagnosis, and management","volume":"92","author":"Feuerstein","year":"2017","journal-title":"Mayo Clin Proc."},{"key":"10.1016\/j.trsl.2019.03.005_bib0006","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1097\/MIB.0000000000000080","article-title":"Fibrosis in ulcerative colitis: mechanisms, features, and consequences of a neglected problem","volume":"20","author":"Gordon","year":"2014","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.trsl.2019.03.005_bib0007","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrneph.2011.149","article-title":"Cellular and molecular mechanisms of renal fibrosis","volume":"7","author":"Liu","year":"2011","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.trsl.2019.03.005_bib0008","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","article-title":"Cellular and molecular mechanisms of fibrosis","volume":"214","author":"Wynn","year":"2008","journal-title":"J Pathol."},{"key":"10.1016\/j.trsl.2019.03.005_bib0009","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn's disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2019.03.005_bib0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, Management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0011","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1136\/gutjnl-2012-304353","article-title":"Crohn's disease complicated by strictures: a systematic review","volume":"62","author":"Rieder","year":"2013","journal-title":"Gut."},{"key":"10.1016\/j.trsl.2019.03.005_bib0012","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1002\/ibd.20590","article-title":"Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease","volume":"14","author":"Bataille","year":"2008","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.trsl.2019.03.005_bib0013","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MOG.0000000000000361","article-title":"Surgical rates in the era of biological therapy: up, down or unchanged?","volume":"33","author":"Olivera","year":"2017","journal-title":"Curr Opin Gastroenterol."},{"key":"10.1016\/j.trsl.2019.03.005_bib0014","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.15585\/mmwr.mm6542a3","article-title":"Prevalence of inflammatory bowel disease among adults aged >\/=18 years - United States, 2015","volume":"65","author":"Dahlhamer","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.trsl.2019.03.005_bib0015","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.crohns.2013.09.001","article-title":"National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States","volume":"8","author":"Nguyen","year":"2014","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0016","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2036.2009.04033.x","article-title":"Cost-effectiveness of biological therapy for Crohn's disease: Markov cohort analyses incorporating United Kingdom patient-level cost data","volume":"30","author":"Bodger","year":"2009","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1016\/j.trsl.2019.03.005_bib0017","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0016-5085(99)70549-4","article-title":"Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort","volume":"117","author":"Silverstein","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0018","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/gutjnl-2011-301971","article-title":"Factors affecting outcomes in Crohn's disease over 15 years","volume":"61","author":"Cosnes","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0019","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1572-0241.2006.01010.x","article-title":"Fibrogenesis in Crohn's disease","volume":"102","author":"Burke","year":"2007","journal-title":"Am J Gastroenterol."},{"key":"10.1016\/j.trsl.2019.03.005_bib0020","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1072-7515(01)00775-X","article-title":"Safety and longterm efficacy of strictureplasty in 314 patients with obstructing small bowel Crohn's disease","volume":"192","author":"Dietz","year":"2001","journal-title":"J Am Coll Surg."},{"key":"10.1016\/j.trsl.2019.03.005_bib0021","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/ibd\/izy331","article-title":"The mesenteric fat and intestinal muscle interface: creeping fat influencing stricture formation in Crohn's disease","author":"Mao","year":"2019","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0022","first-page":"144","article-title":"Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as marker of phenotypic modulations","volume":"63","author":"Sappino","year":"1990","journal-title":"Lab Investig"},{"key":"10.1016\/j.trsl.2019.03.005_bib0023","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00535-010-0232-6","article-title":"Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn's disease: relevance to local angiotensin II system","volume":"45","author":"Suekane","year":"2010","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0024","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yexmp.2005.04.006","article-title":"Deficient innervation characterizes intestinal strictures in a rat model of colitis","volume":"80","author":"Marlow","year":"2006","journal-title":"Exp Mol Pathol."},{"key":"10.1016\/j.trsl.2019.03.005_bib0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nrgastro.2009.31","article-title":"Intestinal fibrosis in IBD\u2013a dynamic, multifactorial process","volume":"6","author":"Rieder","year":"2009","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0026","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/gut.2006.090456","article-title":"Wound healing and fibrosis in intestinal disease","volume":"56","author":"Rieder","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0027","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/MOG.0b013e3282ff8b36","article-title":"Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science","volume":"24","author":"Rieder","year":"2008","journal-title":"Curr Opin Gastroenterol."},{"key":"10.1016\/j.trsl.2019.03.005_bib0028","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/ibd.21543","article-title":"N-cadherin is overexpressed in Crohn's stricture fibroblasts and promotes intestinal fibroblast migration","volume":"17","author":"Burke","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.trsl.2019.03.005_bib0029","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fmed.2017.00126","article-title":"The role of cytokines in the fibrotic responses in Crohn's disease","volume":"4","author":"Curciarello","year":"2017","journal-title":"Front Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/003655202317284228","article-title":"Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts","volume":"37","author":"Okuno","year":"2002","journal-title":"Scand J Gastroenterol."},{"key":"10.1016\/j.trsl.2019.03.005_bib0031","doi-asserted-by":"crossref","first-page":"e52332","DOI":"10.1371\/journal.pone.0052332","article-title":"IL-13 promotes collagen accumulation in Crohn's disease fibrosis by down-regulation of fibroblast MMP synthesis: a role for innate lymphoid cells?","volume":"7","author":"Bailey","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.03.005_bib0032","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1136\/gut.2006.093187","article-title":"Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21","volume":"55","author":"Monteleone","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0033","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/gutjnl-2015-310374","article-title":"IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivo","volume":"66","author":"Scheibe","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0034","article-title":"Inhibiting interleukin 36 receptor signaling reduces fibrosis in mice with chronic intestinal inflammation","author":"Scheibe","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0035","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.3748\/wjg.14.5133","article-title":"Roles of galectins in inflammatory bowel disease","volume":"14","author":"Hokama","year":"2008","journal-title":"World J Gastroenterol."},{"key":"10.1016\/j.trsl.2019.03.005_bib0036","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gut.2005.081646","article-title":"Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factor","volume":"56","author":"Lippert","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0037","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00054725-200108000-00008","article-title":"Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease","volume":"7","author":"Lawrance","year":"2001","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.trsl.2019.03.005_bib0038","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200204000-00008","article-title":"Increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease is secondary to inflammation","volume":"235","author":"Brannigan","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.trsl.2019.03.005_bib0039","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.dld.2007.05.010","article-title":"Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype","volume":"39","author":"Meijer","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0040","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0002-9440(10)63931-4","article-title":"Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease","volume":"162","author":"McKaig","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0041","doi-asserted-by":"crossref","first-page":"C435","DOI":"10.1152\/ajpcell.00035.2004","article-title":"Interleukin-13 augments transforming growth factor-beta1-induced tissue inhibitor of metalloproteinase-1 expression in primary human airway fibroblasts","volume":"288","author":"Zhou","year":"2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2456179","article-title":"Expressions of matrix metalloproteinases (MMP-2, MMP-7, and MMP-9) and their inhibitors (TIMP-1, TIMP-2) in inflammatory bowel diseases","volume":"2016","author":"Jakubowska","year":"2016","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.trsl.2019.03.005_bib0043","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/MIB.0000000000000716","article-title":"Decreased fibrogenesis after treatment with pirfenidone in a newly developed mouse model of intestinal fibrosis","volume":"22","author":"Meier","year":"2016","journal-title":"Inflamm Bowel Dis."},{"key":"10.1016\/j.trsl.2019.03.005_bib0044","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1002\/dvdy.22280","article-title":"Cardiac fibroblast to myofibroblast differentiation in vivo and in vitro: expression of focal adhesion components in neonatal and adult rat ventricular myofibroblasts","volume":"239","author":"Santiago","year":"2010","journal-title":"Dev Dyn"},{"key":"10.1016\/j.trsl.2019.03.005_bib0045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/FJC.0b013e3182116e39","article-title":"Fibroblasts and myofibroblasts: what are we talking about?","volume":"57","author":"Baum","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0046","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/ecco-jcc\/jjy036","article-title":"Fibrostenotic phenotype of myofibroblasts in Crohn's disease is dependent on tissue stiffness and reversed by LOX inhibition","volume":"12","author":"de Bruyn","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0047","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.3748\/wjg.v18.i28.3635","article-title":"Cellular and molecular mechanisms of intestinal fibrosis","volume":"18","author":"Speca","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0048","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm.2807","article-title":"Mechanisms of fibrosis: therapeutic translation for fibrotic disease","volume":"18","author":"Wynn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0049","doi-asserted-by":"crossref","first-page":"G677","DOI":"10.1152\/ajpgi.00104.2011","article-title":"Themes in fibrosis and gastrointestinal inflammation","volume":"300","author":"Fiocchi","year":"2011","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/0962935031000096917","article-title":"Human intestinal epithelial and smooth muscle cells are potent producers of IL-6","volume":"12","author":"Ng","year":"2003","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.trsl.2019.03.005_bib0051","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1053\/j.gastro.2017.06.013","article-title":"Treatment of intestinal fibrosis in experimental inflammatory bowel disease by the pleiotropic actions of a local rho kinase inhibitor","volume":"153","author":"Holvoet","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0052","first-page":"589","article-title":"Myofibroblast-derived smooth muscle cells during remodelling of rabbit urinary bladder wall induced by partial outflow obstruction","volume":"69","author":"Buoro","year":"1993","journal-title":"Lab Investig"},{"key":"10.1016\/j.trsl.2019.03.005_bib0053","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1023\/A:1003216124761","article-title":"Transforming growth factor beta1 involvement in the conversion of fibroblasts to smooth muscle cells in the rabbit bladder serosa","volume":"30","author":"Roelofs","year":"1998","journal-title":"Histochem J."},{"key":"10.1016\/j.trsl.2019.03.005_bib0054","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/thx.2005.050005","article-title":"Enhanced upregulation of smooth muscle related transcripts by TGF beta2 in asthmatic (myo) fibroblasts","volume":"61","author":"Wicks","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.trsl.2019.03.005_bib0055","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ecco-jcc\/jjw126","article-title":"Smooth muscle hyperplasia\/hypertrophy is the most prominent histological change in Crohn's fibrostenosing bowel strictures: a semiquantitative analysis by using a novel histological grading scheme","volume":"11","author":"Chen","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0056","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.5858\/2001-125-1331-OMOTSB","article-title":"Obliterative muscularization of the small bowel submucosa in Crohn disease: a possible mechanism of small bowel obstruction","volume":"125","author":"Koukoulis","year":"2001","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0057","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/j.gastro.2009.09.003","article-title":"Endogenous IGF-I and alphaVbeta3 integrin ligands regulate increased smooth muscle hyperplasia in stricturing Crohn's disease","volume":"138","author":"Flynn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0058","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1097\/MIB.0b013e3182a8452e","article-title":"Increased activation of latent TGF-beta1 by alphaVbeta3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide","volume":"19","author":"Li","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0059","doi-asserted-by":"crossref","first-page":"C722","DOI":"10.1152\/ajpcell.00216.2018","article-title":"Epigenetic modification of intestinal smooth muscle cell phenotype during proliferation","volume":"315","author":"Bonafiglia","year":"2018","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0060","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0016-5085(87)90134-X","article-title":"Collagen synthesis by human intestinal smooth muscle cells in culture","volume":"92","author":"Graham","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0061","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s10620-013-2813-8","article-title":"Fibrocytes are involved in inflammation as well as fibrosis in the pathogenesis of Crohn's disease","volume":"59","author":"Sazuka","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.trsl.2019.03.005_bib0062","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.21037\/atm.2016.10.26","article-title":"Circulating fibrocytes serve as a marker for clinical diagnosis","volume":"4","author":"Cao","year":"2016","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0063","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10620-013-2888-2","article-title":"Fibrocytes, inflammation, and fibrosis in Crohn's disease: another piece of the puzzle","volume":"59","author":"Sorrentino","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.trsl.2019.03.005_bib0064","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.biocel.2003.10.005","article-title":"Circulating fibrocytes: collagen-secreting cells of the peripheral blood","volume":"36","author":"Quan","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0065","doi-asserted-by":"crossref","first-page":"6307","DOI":"10.1073\/pnas.94.12.6307","article-title":"The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T cells in situ","volume":"94","author":"Chesney","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.03.005_bib0066","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/bjs.9302","article-title":"Circulating fibrocytes and Crohn's disease","volume":"100","author":"Sahebally","year":"2013","journal-title":"Br J Surg"},{"key":"10.1016\/j.trsl.2019.03.005_bib0067","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10620-009-0730-7","article-title":"Emergence of fibrocytes showing morphological changes in the inflamed colonic mucosa","volume":"55","author":"Uehara","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.trsl.2019.03.005_bib0068","doi-asserted-by":"crossref","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","article-title":"Therapy for fibrotic diseases: nearing the starting line","volume":"5","author":"Friedman","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0069","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.crohns.2012.04.008","article-title":"Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis","volume":"7","author":"Drygiannakis","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0070","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1172\/JCI42090","article-title":"Epithelium-specific deletion of TGF-beta receptor type II protects mice from bleomycin-induced pulmonary fibrosis","volume":"121","author":"Li","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.trsl.2019.03.005_bib0071","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1128\/MCB.01218-10","article-title":"Hepatocyte-derived Snail1 propagates liver fibrosis progression","volume":"31","author":"Rowe","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0072","doi-asserted-by":"crossref","first-page":"35635","DOI":"10.1038\/srep35635","article-title":"Early detection of T cell transfer-induced autoimmune colitis by in vivo imaging system","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.trsl.2019.03.005_bib0073","doi-asserted-by":"crossref","first-page":"20202","DOI":"10.1074\/jbc.M110.102012","article-title":"Identification of epithelial to mesenchymal transition as a novel source of fibroblasts in intestinal fibrosis","volume":"285","author":"Flier","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2019.03.005_bib0074","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1165\/rcmb.2009-0031OC","article-title":"Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis","volume":"43","author":"Hashimoto","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0075","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1681\/ASN.2008050513","article-title":"Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition","volume":"19","author":"Zeisberg","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0076","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.ajpath.2011.07.042","article-title":"Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis","volume":"179","author":"Rieder","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0077","first-page":"120","article-title":"Managing intestinal fibrosis in patients with inflammatory Bowel disease","volume":"14","author":"Rieder","year":"2018","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0078","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MOG.0000000000000119","article-title":"Central role of IL-17\/Th17 immune responses and the gut microbiota in the pathogenesis of intestinal fibrosis","volume":"30","author":"Ray","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0079","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/S0140-6736(12)60026-9","article-title":"Crohn's disease","volume":"380","author":"Baumgart","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2019.03.005_bib0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajpath.2012.03.044","article-title":"Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies","volume":"181","author":"Maddur","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0081","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/gut.52.1.65","article-title":"Increased expression of interleukin 17 in inflammatory bowel disease","volume":"52","author":"Fujino","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0082","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/ibd.20475","article-title":"IL-23\/IL-17 immunity as a hallmark of Crohn's disease","volume":"14","author":"Holtta","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0083","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-1536-6-13","article-title":"The role of interleukin 17 in Crohn's disease-associated intestinal fibrosis","volume":"6","author":"Biancheri","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.trsl.2019.03.005_bib0084","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1007\/s10620-018-5234-x","article-title":"IL-17A promotes initiation and development of intestinal fibrosis through EMT","volume":"63","author":"Zhang","year":"2018","journal-title":"Dig Dis Sci."},{"key":"10.1016\/j.trsl.2019.03.005_bib0085","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1136\/gutjnl-2011-301668","article-title":"Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial","volume":"61","author":"Hueber","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0086","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri.2017.90","article-title":"Type 2 immunity in tissue repair and fibrosis","volume":"18","author":"Gieseck","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0087","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0088","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1172\/JCI8124","article-title":"Airway remodeling in asthma","volume":"104","author":"Elias","year":"1999","journal-title":"J Clin Investig"},{"key":"10.1016\/j.trsl.2019.03.005_bib0089","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1084\/jem.194.6.809","article-title":"Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1)","volume":"194","author":"Lee","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0090","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.4049\/jimmunol.178.9.5859","article-title":"Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis","volume":"178","author":"Fichtner-Feigl","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0091","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1164\/rccm.201403-0509PP","article-title":"New therapeutic targets in idiopathic pulmonary fibrosis. Aiming to rein in runaway wound-healing responses","volume":"190","author":"Ahluwalia","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0092","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gutjnl-2014-308004","article-title":"Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study","volume":"64","author":"Danese","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0093","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1136\/gutjnl-2014-308337","article-title":"Anrukinzumab, an anti-interleukin 13 monoclonal antibody, in active UC: efficacy and safety from a phase IIa randomised multicentre study","volume":"64","author":"Reinisch","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0094","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/ecco-jcc\/jjx185","article-title":"CD16+ macrophages mediate fibrosis in inflammatory bowel disease","volume":"12","author":"Salvador","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0095","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.immuni.2016.02.015","article-title":"Macrophages in tissue repair, regeneration, and fibrosis","volume":"44","author":"Wynn","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2019.03.005_bib0096","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI200522675","article-title":"Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair","volume":"115","author":"Duffield","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.trsl.2019.03.005_bib0097","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/CS20060242","article-title":"Liver fibrosis: cellular mechanisms of progression and resolution","volume":"112","author":"Henderson","year":"2007","journal-title":"Clin Sci"},{"key":"10.1016\/j.trsl.2019.03.005_bib0098","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1172\/JCI31546","article-title":"IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice","volume":"117","author":"Wilson","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.trsl.2019.03.005_bib0099","doi-asserted-by":"crossref","first-page":"G323","DOI":"10.1152\/ajpgi.00394.2009","article-title":"Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis","volume":"298","author":"Popov","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jhep.2008.01.032","article-title":"Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury","volume":"49","author":"Douglass","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0101","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nri1733","article-title":"Monocyte and macrophage heterogeneity","volume":"5","author":"Gordon","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0102","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.4049\/jimmunol.167.11.6533","article-title":"Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1\/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism","volume":"167","author":"Hesse","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0103","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S1074-7613(04)00107-4","article-title":"Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology","volume":"20","author":"Herbert","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2019.03.005_bib0104","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1681\/ASN.2016050573","article-title":"Macrophage-to-myofibroblast transition contributes to interstitial fibrosis in chronic renal allograft injury","volume":"28","author":"Wang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0105","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fimmu.2015.00613","article-title":"Diversity of intestinal macrophages in inflammatory bowel diseases","volume":"6","author":"Kuhl","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0106","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1172\/JCI200519229","article-title":"Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity","volume":"115","author":"Smythies","year":"2005","journal-title":"J Clin Investig"},{"key":"10.1016\/j.trsl.2019.03.005_bib0107","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1159\/000233291","article-title":"Can we modulate the clinical course of inflammatory bowel diseases by our current treatment strategies?","volume":"27","author":"Cosnes","year":"2009","journal-title":"Dig Dis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0108","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SLA.0b013e3181e61df5","article-title":"Trends in surgery for Crohn's disease in the era of infliximab","volume":"252","author":"Jones","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.trsl.2019.03.005_bib0109","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2006.03134.x","article-title":"Review article: Altering the natural history of Crohn's disease\u2013evidence for and against current therapies","volume":"25","author":"Vermeire","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.trsl.2019.03.005_bib0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrd.2015.10","article-title":"Integrin-based therapeutics: biological basis, clinical use and new drugs","volume":"15","author":"Ley","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.trsl.2019.03.005_bib0111","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1126\/science.1163865","article-title":"The tail of integrins, talin, and kindlins","volume":"324","author":"Moser","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.trsl.2019.03.005_bib0112","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1126\/science.1086652","article-title":"Talin binding to integrin beta tails: a final common step in integrin activation","volume":"302","author":"Tadokoro","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.trsl.2019.03.005_bib0113","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/ni1407","article-title":"Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs","volume":"7","author":"Mocsai","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0114","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S1074-7613(02)00303-5","article-title":"Syk is required for integrin signaling in neutrophils","volume":"16","author":"Mocsai","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2019.03.005_bib0115","doi-asserted-by":"crossref","first-page":"13298","DOI":"10.1073\/pnas.2336149100","article-title":"Src kinase activation by direct interaction with the integrin beta cytoplasmic domain","volume":"100","author":"Arias-Salgado","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.03.005_bib0116","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.3748\/wjg.v24.i17.1868","article-title":"Anti-integrin therapy for inflammatory bowel disease","volume":"24","author":"Park","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0117","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1084\/jem.188.1.119","article-title":"Spontaneous skin ulceration and defective T cell function in CD18 null mice","volume":"188","author":"Scharffetter-Kochanek","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0118","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ng.3760","article-title":"Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease","volume":"49","author":"de Lange","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.trsl.2019.03.005_bib0119","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0092-8674(93)90305-A","article-title":"Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1","volume":"74","author":"Berlin","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2019.03.005_bib0120","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.immuni.2004.08.011","article-title":"Retinoic acid imprints gut-homing specificity on T cells","volume":"21","author":"Iwata","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.trsl.2019.03.005_bib0121","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00384-006-0188-4","article-title":"Evidence for a differential expression of fibronectin splice forms ED-A and ED-B in Crohn's disease (CD) mucosa","volume":"22","author":"Brenmoehl","year":"2007","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0122","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ncb2747","article-title":"beta1- and alphav-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments","volume":"15","author":"Schiller","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0123","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0124","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/MIB.0b013e3182813297","article-title":"Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts","volume":"19","author":"Johnson","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0125","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1042\/BST0360149","article-title":"Regulation of cell-cell adhesion by the cadherin-catenin complex","volume":"36","author":"Nelson","year":"2008","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.trsl.2019.03.005_bib0126","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/bcr3065","article-title":"The role and function of cadherins in the mammary gland","volume":"14","author":"Andrews","year":"2012","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.trsl.2019.03.005_bib0127","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1111\/jcmm.13836","article-title":"Epithelial down-regulation of the miR-200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition","volume":"22","author":"Mehta","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40169-015-0046-5","article-title":"Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis","volume":"4","author":"Scharl","year":"2015","journal-title":"Clin Transl Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0129","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/jcmm.12869","article-title":"Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases - hallmark of epithelial-mesenchymal transition","volume":"20","author":"Zidar","year":"2016","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0130","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1137306","article-title":"Cadherin-11 in synovial lining formation and pathology in arthritis","volume":"315","author":"Lee","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.trsl.2019.03.005_bib0131","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.clim.2014.08.008","article-title":"Cadherin-11 mRNA transcripts are frequently found in rheumatoid arthritis peripheral blood and correlate with established polyarthritis","volume":"155","author":"Sfikakis","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0132","doi-asserted-by":"crossref","first-page":"8402","DOI":"10.1073\/pnas.1019437108","article-title":"Cadherin-11 regulates fibroblast inflammation","volume":"108","author":"Chang","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.03.005_bib0133","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1002\/art.30630","article-title":"Modulation of matrix metalloproteinase production by rheumatoid arthritis synovial fibroblasts after cadherin 11 engagement","volume":"63","author":"Noss","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2019.03.005_bib0134","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1161\/ATVBAHA.116.307812","article-title":"Cadherin-11 overexpression induces extracellular matrix remodeling and calcification in mature aortic valves","volume":"36","author":"Sung","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0135","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/art.21894","article-title":"Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts","volume":"54","author":"Gardner","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2019.03.005_bib0136","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1096\/fj.11-186098","article-title":"Cadherin-11 contributes to pulmonary fibrosis: potential role in TGF-beta production and epithelial to mesenchymal transition","volume":"26","author":"Schneider","year":"2012","journal-title":"FASEB J"},{"key":"10.1016\/j.trsl.2019.03.005_bib0137","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1681\/ASN.2015020225","article-title":"RNA sequencing identifies novel translational biomarkers of kidney fibrosis","volume":"27","author":"Craciun","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0138","doi-asserted-by":"crossref","first-page":"e199","DOI":"10.1371\/journal.pmed.0020199","article-title":"Dissection of the inflammatory bowel disease transcriptome using genome-wide cDNA microarrays","volume":"2","author":"Costello","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0139","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1038\/emm.2016.95","article-title":"Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis","volume":"48","author":"Jeong","year":"2016","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0140","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00726-008-0124-8","article-title":"Transglutaminases and their substrates in biology and human diseases: 50 years of growing","volume":"36","author":"Facchiano","year":"2009","journal-title":"Amino Acids"},{"key":"10.1016\/j.trsl.2019.03.005_bib0141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-394305-7.00001-X","article-title":"Cellular functions of tissue transglutaminase","volume":"294","author":"Nurminskaya","year":"2012","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0142","doi-asserted-by":"crossref","first-page":"15308","DOI":"10.1016\/S0021-9258(18)98617-5","article-title":"Cross-linking of laminin-nidogen complexes by tissue transglutaminase. A novel mechanism for basement membrane stabilization","volume":"266","author":"Aeschlimann","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2019.03.005_bib0143","doi-asserted-by":"crossref","first-page":"14015","DOI":"10.1016\/S0021-9258(18)68178-5","article-title":"Dissociation of fibrinogen and fibronectin binding from transglutaminase-mediated cross-linking at the hepatocyte surface","volume":"263","author":"Barsigian","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2019.03.005_bib0144","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrm1014","article-title":"Transglutaminases: crosslinking enzymes with pleiotropic functions","volume":"4","author":"Lorand","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0145","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1083\/jcb.121.2.439","article-title":"Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells","volume":"121","author":"Kojima","year":"1993","journal-title":"J Cell Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0146","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00726-011-1008-x","article-title":"TG2, a novel extracellular protein with multiple functions","volume":"42","author":"Wang","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.trsl.2019.03.005_bib0147","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1084\/jem.20101457","article-title":"Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice","volume":"208","author":"Oh","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0148","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1177\/002215549904701108","article-title":"Regulation of cell surface tissue transglutaminase: effects on matrix storage of latent transforming growth factor-beta binding protein-1","volume":"47","author":"Verderio","year":"1999","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.trsl.2019.03.005_bib0149","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/gut.37.5.690","article-title":"Transglutaminases in Crohn's disease","volume":"37","author":"D'Argenio","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0150","doi-asserted-by":"crossref","first-page":"21291","DOI":"10.1074\/jbc.274.30.21291","article-title":"Cardiac specific overexpression of transglutaminase II (G(h)) results in a unique hypertrophy phenotype independent of phospholipase C activation","volume":"274","author":"Small","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2019.03.005_bib0151","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/cvr\/cvx053","article-title":"Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling","volume":"113","author":"Shinde","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2019.03.005_bib0152","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yjmcc.2018.02.016","article-title":"Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload","volume":"117","author":"Shinde","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0153","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.kint.2016.01.030","article-title":"Endostatin and transglutaminase 2 are involved in fibrosis of the aging kidney","volume":"89","author":"Lin","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.trsl.2019.03.005_bib0154","doi-asserted-by":"crossref","first-page":"L752","DOI":"10.1152\/ajplung.00170.2017","article-title":"Transglutaminase 2 in pulmonary and cardiac tissue remodeling in experimental pulmonary hypertension","volume":"313","author":"Penumatsa","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0155","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/exd.13449","article-title":"Transglutaminases in autoimmune and inherited skin diseases: The phenomena of epitope spreading and functional compensation","volume":"27","author":"Karpati","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0156","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/14728222.2016.1151003","article-title":"Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer","volume":"20","author":"Trackman","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.trsl.2019.03.005_bib0157","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1165\/ajrcmb\/5.3.206","article-title":"Properties and function of lysyl oxidase","volume":"5","author":"Kagan","year":"1991","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0158","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1600-0625.2010.01135.x","article-title":"Lysyl oxidase silencing impairs keratinocyte differentiation in a reconstructed-epidermis model","volume":"19","author":"Le Provost","year":"2010","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0159","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1074\/jbc.M110.155622","article-title":"Lysyl oxidase-like-2 (LOXL2) is a major isoform in chondrocytes and is critically required for differentiation","volume":"286","author":"Iftikhar","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2019.03.005_bib0160","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1158\/0008-5472.CAN-06-3867","article-title":"The tumor suppressor activity of the lysyl oxidase propeptide reverses the invasive phenotype of Her-2\/neu-driven breast cancer","volume":"67","author":"Min","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.03.005_bib0161","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nature04695","article-title":"Lysyl oxidase is essential for hypoxia-induced metastasis","volume":"440","author":"Erler","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.03.005_bib0162","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100669","article-title":"A novel function for lysyl oxidase in pluripotent mesenchymal cell proliferation and relevance to inflammation-associated osteopenia","volume":"9","author":"Khosravi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.trsl.2019.03.005_bib0163","doi-asserted-by":"crossref","first-page":"11429","DOI":"10.1158\/0008-5472.CAN-05-1274","article-title":"Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism","volume":"65","author":"Payne","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.trsl.2019.03.005_bib0164","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1182\/blood-2010-10-313296","article-title":"Lysyl oxidase-like protein-2 regulates sprouting angiogenesis and type IV collagen assembly in the endothelial basement membrane","volume":"118","author":"Bignon","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2019.03.005_bib0165","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/jcb.10413","article-title":"Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell","volume":"88","author":"Kagan","year":"2003","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.trsl.2019.03.005_bib0166","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.114.303534","article-title":"Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension","volume":"34","author":"Nave","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0167","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1074\/jbc.M115.691519","article-title":"Molecular mechanism responsible for fibronectin-controlled alterations in matrix stiffness in advanced chronic liver fibrogenesis","volume":"291","author":"Iwasaki","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.trsl.2019.03.005_bib0168","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/gast.1996.v111.pm8698196","article-title":"Mechanism of collagen network stabilization in human irreversible granulomatous liver fibrosis","volume":"111","author":"Ricard-Blum","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0169","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.yjmcc.2015.05.019","article-title":"Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice","volume":"85","author":"Adam","year":"2015","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0170","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ajpath.2014.11.009","article-title":"Disruption of collagen homeostasis can reverse established age-related myocardial fibrosis","volume":"185","author":"Rosin","year":"2015","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0171","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S2213-2600(16)30421-0","article-title":"Efficacy of simtuzumab versus placebo in patients with idiopathic pulmonary fibrosis: a randomised, double-blind, controlled, phase 2 trial","volume":"5","author":"Raghu","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0172","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1136\/gutjnl-2016-312473","article-title":"Selective targeting of lysyl oxidase-like 2 (LOXL2) suppresses hepatic fibrosis progression and accelerates its reversal","volume":"66","author":"Ikenaga","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0173","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1053\/j.gastro.2018.07.006","article-title":"Simtuzumab is ineffective for patients with bridging fibrosis or compensated cirrhosis caused by nonalcoholic steatohepatitis","volume":"155","author":"Harrison","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0174","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/jech-2011-200726","article-title":"Discovering environmental causes of disease","volume":"66","author":"Rappaport","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.trsl.2019.03.005_bib0175","doi-asserted-by":"crossref","first-page":"190ps10","DOI":"10.1126\/scitranslmed.3004731","article-title":"The gut microbiome in intestinal fibrosis: environmental protector or provocateur?","volume":"5","author":"Rieder","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0176","doi-asserted-by":"crossref","DOI":"10.1038\/s41385-019-0138-4","article-title":"Flagellin-mediated activation of IL-33-ST2 signaling by a pathobiont promotes intestinal fibrosis","author":"Imai","year":"2019","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0177","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2019.03.005_bib0178","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.4161\/cc.21572","article-title":"Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K","volume":"11","author":"Troutman","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.trsl.2019.03.005_bib0179","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nri1391","article-title":"Toll-like receptor signalling","volume":"4","author":"Akira","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0180","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3109\/00365529709011206","article-title":"Prognostic value of plasma endotoxin levels in patients with cirrhosis","volume":"32","author":"Chan","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0181","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0168-8278(95)80424-2","article-title":"Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation","volume":"22","author":"Lin","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0182","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0183","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/154405910708600310","article-title":"Functional TLRs and NODs in human gingival fibroblasts","volume":"86","author":"Uehara","year":"2007","journal-title":"J Dent Res"},{"key":"10.1016\/j.trsl.2019.03.005_bib0184","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0016-5085(03)00403-7","article-title":"Intestinal myofibroblasts in innate immune responses of the intestine","volume":"124","author":"Otte","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0185","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ni1362","article-title":"Detection of pathogenic intestinal bacteria by Toll-like receptor 5 on intestinal CD11c+ lamina propria cells","volume":"7","author":"Uematsu","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0186","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1016\/S0016-5085(11)60462-9","article-title":"Activation of Toll- like receptor (TLR) 5 Induces a pro-fibrogenic phenotype on human intestinal myofibroblasts (HIF)\u2014a novel pathway mediated by caspase 1 (Abstract)","volume":"140","author":"Rieder","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0187","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0046-8177(80)80073-6","article-title":"Crohn's disease: transmission electron microscopic studies. III. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system","volume":"11","author":"Dvorak","year":"1980","journal-title":"Hum Pathol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0188","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.1979.59.1.1","article-title":"The smooth muscle cell in culture","volume":"59","author":"Chamley-Campbell","year":"1979","journal-title":"Physiol Rev"},{"key":"10.1016\/j.trsl.2019.03.005_bib0189","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1152\/physiolgenomics.00160.2011","article-title":"Interleukin-1beta modulates smooth muscle cell phenotype to a distinct inflammatory state relative to PDGF-DD via NF-kappaB-dependent mechanisms","volume":"44","author":"Alexander","year":"2012","journal-title":"Physiol Genom"},{"key":"10.1016\/j.trsl.2019.03.005_bib0190","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5551\/jat.9746","article-title":"Novel TNF-alpha receptor 1 antagonist treatment attenuates arterial inflammation and intimal hyperplasia in mice","volume":"19","author":"Kitagaki","year":"2012","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.trsl.2019.03.005_bib0191","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ecl.2012.04.018","article-title":"Insulin-like growth factors in the gastrointestinal tract and liver","volume":"41","author":"Kuemmerle","year":"2012","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.trsl.2019.03.005_bib0192","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0002-9343(52)90025-9","article-title":"Regional ileitis; a pathologic and clinical entity","volume":"13","author":"Crohn","year":"1952","journal-title":"Am J Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0193","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fimmu.2014.00462","article-title":"Adipose-tissue and intestinal inflammation - visceral obesity and creeping fat","volume":"5","author":"Kredel","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0194","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/gut.2005.082925","article-title":"Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?","volume":"56","author":"Peyrin-Biroulet","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0195","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/MIB.0000000000000209","article-title":"Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel","volume":"21","author":"Goncalves","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.trsl.2019.03.005_bib0196","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","article-title":"What we talk about when we talk about fat","volume":"156","author":"Rosen","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.trsl.2019.03.005_bib0197","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/cvr\/cvv208","article-title":"Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location","volume":"108","author":"Gaborit","year":"2015","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2019.03.005_bib0198","first-page":"279","article-title":"Adenovirusmediated knockdown of activin A receptor type 2A attenuates immuneinduced hepatic fibrosis in mice and inhibits interleukin17induced activation of primary hepatic stellate cells","volume":"42","author":"Zhang","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.trsl.2019.03.005_bib0199","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/cvr\/cvw001","article-title":"Cardiac adipose tissue and atrial fibrillation: the perils of adiposity","volume":"109","author":"Hatem","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.trsl.2019.03.005_bib0200","first-page":"S","article-title":"Creeping-fat derived free fatty acids induce hyperplasia of intestinal muscularis propria muscle cells \u2013 a novel link between fat and intestinal stricture formation in Crohn's disease (abstract)","volume":"154","author":"Mao","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0201","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/gast.2003.50148","article-title":"Emergence of perianal fistulizing disease in the SAMP1\/YitFc mouse, a spontaneous model of chronic ileitis","volume":"124","author":"Rivera-Nieves","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0202","doi-asserted-by":"crossref","first-page":"G786","DOI":"10.1152\/ajpgi.00059.2012","article-title":"Animal models of intestinal fibrosis: new tools for the understanding of pathogenesis and therapy of human disease","volume":"303","author":"Rieder","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0203","doi-asserted-by":"crossref","first-page":"G829","DOI":"10.1152\/ajpgi.2000.278.6.G829","article-title":"Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-\/-) mice and intestinal inflammation","volume":"278","author":"Rennick","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0204","doi-asserted-by":"crossref","first-page":"12215","DOI":"10.1073\/pnas.92.26.12215","article-title":"Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated","volume":"92","author":"Diebold","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.trsl.2019.03.005_bib0205","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/gut.2005.068429","article-title":"Induction of a fibrogenic response in mouse colon by overexpression of monocyte chemoattractant protein 1","volume":"55","author":"Motomura","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0206","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00001574-200107000-00004","article-title":"Intestinal fibrosis in human and experimental inflammatory bowel disease","volume":"17","author":"Lund","year":"2001","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0207","doi-asserted-by":"crossref","first-page":"G116","DOI":"10.1152\/ajpgi.00051.2005","article-title":"TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis","volume":"289","author":"Vallance","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0208","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat Protoc"},{"key":"10.1016\/j.trsl.2019.03.005_bib0209","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0016-5085(94)90803-6","article-title":"Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice","volume":"107","author":"Dieleman","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0210","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1172\/JCI200215256","article-title":"Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis","volume":"110","author":"Krieglstein","year":"2002","journal-title":"J Clin Investig"},{"key":"10.1016\/j.trsl.2019.03.005_bib0211","doi-asserted-by":"crossref","first-page":"G1328","DOI":"10.1152\/ajpgi.00467.2004","article-title":"Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL\/6 but not in BALB\/c mice: correlation between symptoms and inflammation","volume":"288","author":"Melgar","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0212","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1053\/gast.2002.30308","article-title":"Distinct inflammatory mechanisms mediate early versus late colitis in mice","volume":"122","author":"Spencer","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0213","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/0016-5085(93)91063-N","article-title":"Peroxynitrite-induced rat colitis\u2013a new model of colonic inflammation","volume":"105","author":"Rachmilewitz","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trsl.2019.03.005_bib0214","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1136\/gut.2003.035113","article-title":"CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin","volume":"54","author":"Byrne","year":"2005","journal-title":"Gut"},{"key":"10.1016\/j.trsl.2019.03.005_bib0215","first-page":"1503","article-title":"Inflammatory bowel disease in C.B-17 scid mice reconstituted with the CD45RBhigh subset of CD4+ T cells","volume":"148","author":"Leach","year":"1996","journal-title":"Am J Pathol"},{"key":"10.1016\/j.trsl.2019.03.005_bib0216","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/art.22289","article-title":"Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I\/II trial of CAT-192","volume":"56","author":"Denton","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.trsl.2019.03.005_bib0217","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40265-015-0523-6","article-title":"Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?","volume":"76","author":"Rangarajan","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.trsl.2019.03.005_bib0218","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/2050640616660000","article-title":"Toward an antifibrotic therapy for inflammatory bowel disease","volume":"4","author":"Rieder","year":"2016","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.trsl.2019.03.005_bib0219","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/apt.15032","article-title":"Editorial: treating strictures in inflammatory bowel disease-authors' reply","volume":"48","author":"Rieder","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.trsl.2019.03.005_bib0220","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/apt.14853","article-title":"An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease","volume":"48","author":"Rieder","year":"2018","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441930057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193152441930057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:37:10Z","timestamp":1761827830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193152441930057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":220,"alternative-id":["S193152441930057X"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2019.03.005","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenesis of fibrostenosing Crohn's disease","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2019.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}